Viewing Study NCT03953833


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2025-12-26 @ 1:23 AM
Study NCT ID: NCT03953833
Status: COMPLETED
Last Update Posted: 2023-09-14
First Post: 2019-04-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: B003 in Patients With HER2-positive Recurrent or Metastatic Breast Cancer
Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module